Results 91 to 100 of about 5,715 (232)

Contemporary Surgical Treatment for Hypertrophic Cardiomyopathy [PDF]

open access: yes, 2018
Hypertrophic cardiomyopathy is the most common cause of sudden death in young athletes. Surgical septal myectomy is highly effective for the patients with hypertrophic obstructive cardiomyopathy, which is refractory to medical treatment.
Murashita, Takashi
core   +1 more source

Does Left Atrial Size and E/e′ Predict Outcomes in Hypertrophic Cardiomyopathy?

open access: yesEchocardiography, Volume 42, Issue 11, November 2025.
The current study followed 233 patients with hypertrophic cardiomyopathy, over a median follow‐up of 8 years. Left atrial size but not E/e' were predictive of outcomes related to atrial arrhythmia, and none were predictive of all‐cause mortality in multivariate analysis.
Brandon Tillson   +2 more
wiley   +1 more source

Precision myectomy: Real-time on-pump intracardiac echocardiography for resection in patients with thin septaCentral MessagePerspective

open access: yesJTCVS Techniques
Objective: During septal myectomy, once the heart is arrested and drained of blood on cardiopulmonary bypass, transesophageal echocardiography can no longer assess septal thickness.
Katherine G. Phillips, MD   +9 more
doaj   +1 more source

Etude de l'évolution des patients porteurs d'une cardiomyopathie hypertrophique obstructive (CMHO) après alcoolisation septale [PDF]

open access: yes, 2014
La cardiomyopathie hypertrophique (CMH) est la maladie cardiaque monogénique la plus fréquente, touchant environ 1 individu sur 500 dans la population (1,2).
CARREL, L.
core  

Expressão fenotípica da miocardiopatia hipertrófica e realce tardio na ressonância magnética cardíaca [PDF]

open access: yes, 2014
INTRODUCTION AND AIM: The prognostic value of late gadolinium enhancement (LGE) for risk stratification of hypertrophic cardiomyopathy (HCM) patients is the subject of disagreement.
Almeida, I   +8 more
core   +1 more source

Incidence and risk factors for pacemaker implantation following aortic valve replacement [PDF]

open access: yes, 2010
Our aim was to identify the predictive factors for permanent pacemaker (PM) implantation in patients undergoing isolated aortic valve replacement (AVR).
Achim Häusler   +22 more
core   +1 more source

Atrial cardiomyopathy

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala   +1 more
wiley   +1 more source

Two‐Year Results of Percutaneous Endocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2763-2769, October 1, 2025.
ABSTRACT Background Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary myocardial disease. Percutaneous endocardial septal radiofrequency ablation (PESA) is an innovative approach for treating HOCM. Consequently, we present the outcomes of the PESA for HOCM. Methods This study included 20 patients with HOCM who received PESA.
NingNing Zheng   +6 more
wiley   +1 more source

Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 5, Page 3416-3425, October 2025.
Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan   +10 more
wiley   +1 more source

Echocardiographic Features of Cardiomyopathies: A Comprehensive Review

open access: yesEchocardiography, Volume 42, Issue 10, October 2025.
Echocardiography remains a cornerstone in the diagnosis and characterization of cardiomyopathies, offering detailed structural and functional insights. This review outlines key echocardiographic features that guide the evaluation of dilated, hypertrophic, restrictive, and non‐compaction cardiomyopathies, enhancing clinical decision‐making.
Ghassan Hamdan Al‐Naami
wiley   +1 more source

Home - About - Disclaimer - Privacy